Ledger.Open graph →
SEC Form D · filed August 14, 2015

CymaBay Therapeutics, Inc

Offering
$325K
Sold
$325K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEWARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Kurt G. Von Emster · Newark, CADirectorSujal A. Shah · Newark, CAExecHarold Van Wart, Ph. D · Newark, CAExec · DirectorCarl G. Goldfischer, M.D · Newark, CADirectorPol J. Boudes · Newark, CAExecHari G. Kumar, Ph.D · Newark, CADirectorCharles A. Mcwherter, Ph. D · Newark, CAExecLouis G. Lange, M.D., Ph.D · Newark, CADirectorRobert J. Wills · Newark, CADirectorSujal A. Shah · Newark, CAExecHarold Van Wart, Ph. D · Newark, CAExec · DirectorCarl G. Goldfischer, M.D · Newark, CADirectorPol J. Boudes · Newark, CAExecKurt G. Von Emster · Newark, CADirectorHari G. Kumar, Ph.D · Newark, CADirectorCharles A. Mcwherter, Ph. D · Newark, CAExecLouis G. Lange, M.D., Ph.D · Newark, CADirectorRobert J. Wills · Newark, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗